DPP4 and pancreatitis: The reported odds ratio (OR) of 0.93 with a 95% confidence interval (CI) of 0.51–1.69 indicates that there is no statistically significant increase in the risk of pancreatitis associated with DPP-4 inhibitors based on the available RCT data.